Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-22 | New | $130,000 | $130,000 | Equity Only | 06b | SEC link |
| 2020-08-17 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| 2018-12-27 | New | $2,160,500 | $2,160,500 | Equity and Debt | 06c | SEC link |
| 2017-05-24 | Amended | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2016-06-16 | New | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2015-11-23 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2014-09-24 | New | $500,000 | $500,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Mark Gold | Director |
| Jamie Grooms | Director |
| Mark Hamister | Director |
| Dan Hamister | Director |
| Gerald Kluft | Director |
| Elad Levy | Director |
| Brian Lipke | Director |
| Jonelle Toothman | Director, Executive |
| Rick Wassel | Director |